MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous manifestations of psoriatic disease need to be considered in treatment targets.

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the completion of the dosing and initial follow-up period for ...

For example, one person with psoriatic arthritis may respond well to a TNF ... Biologics can be used as first-line treatment for some conditions. However, your doctor may recommend starting ...

Immunosuppressants for psoriatic arthritis include methotrexate and biologics like TNF inhibitors. Find out if these drugs might be right for you. Yoga for psoriatic arthritis can help maintain ...

Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.

The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

Treatment persistence varied by biologic therapy use, sex, and diagnostic codes among patients with psoriasis.

Discovering the best way to manage autoimmune conditions Project IMPACT invites individuals undergoing treatment with ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...